Multiple variants of HPV16 E6 gene in cervical invasive squamous cell carcinoma

被引:0
作者
Pang, T
Hu, XR [1 ]
Mazurenko, N
Kisseljov, F
Pontén, J
机构
[1] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden
[2] Blokhin Canc Res Ctr, Moscow 115478, Russia
关键词
HPV; gene variation; cervical cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: HPV16 is the most commonly detected genotype in cervical squamous cell carcinoma. E6 of HPV16 is a viral oncogene and has frequent DNA sequence variations whose encoded proteins have been shown to have heterogeneity in biochemical and biological properties. This study tried to establish whether the E6 variants derive from the infection pool or from spontaneous mutation in the host. Materials and Methods: We combined the use of microdissection of multiple areas of tumor tissue, PCR-sequencing of HPV16 E6 and E5 genes and allele-specific amplification of PCR to analyze the E6 variations in four cases of cervical cancer (M4, M12, M13 and M23). Results: We isolated two common (350G and 350T) and three rare (310G, 374T and 459C) E6 variations corresponding to five different E6 variants. The common E6 variations were always co-segregated with specific E5 variations. Both common variants persisted in all the four cases. Of three cases each had one additional rare E6 variant. Conclusion: The common E6 variants would derive from the infection pool, whereas the rare E6 variants may evolve from the mutation of either of the common E6 variants. This finding might have implications for the future study of natural HPV evolution, the design of viral vaccine and the carcinogenesis of cervical cancer.
引用
收藏
页码:1011 / 1016
页数:6
相关论文
共 34 条
[1]   HUMAN PAPILLOMA-VIRUS DNAS IMMORTALIZE NORMAL HUMAN MAMMARY EPITHELIAL-CELLS AND REDUCE THEIR GROWTH-FACTOR REQUIREMENTS [J].
BAND, V ;
ZAJCHOWSKI, D ;
KULESA, V ;
SAGER, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (01) :463-467
[2]   IDENTIFICATION AND ASSESSMENT OF KNOWN AND NOVEL HUMAN PAPILLOMAVIRUSES BY POLYMERASE CHAIN-REACTION AMPLIFICATION, RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS, NUCLEOTIDE-SEQUENCE, AND PHYLOGENETIC ALGORITHMS [J].
BERNARD, HU ;
CHAN, SY ;
MANOS, MM ;
ONG, CK ;
VILLA, LL ;
DELIUS, H ;
PEYTON, CL ;
BAUER, HM ;
WHEELER, CM .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (05) :1077-1085
[3]   CANCER STATISTICS, 1993 [J].
BORING, CC ;
SQUIRES, TS ;
TONG, T .
CA-A CANCER JOURNAL FOR CLINICIANS, 1993, 43 (01) :7-26
[4]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[5]   DEGRADATION OF P53 CAN BE TARGETED BY HPV E6 SEQUENCES DISTINCT FROM THOSE REQUIRED FOR P53 BINDING AND TRANSACTIVATION [J].
CROOK, T ;
TIDY, JA ;
VOUSDEN, KH .
CELL, 1991, 67 (03) :547-556
[6]   MOLECULAR ANALYSIS OF INTEGRATED HUMAN PAPILLOMAVIRUS-16 SEQUENCES IN THE CERVICAL-CANCER CELL-LINE SIHA [J].
ELAWADY, MK ;
KAPLAN, JB ;
OBRIEN, SJ ;
BURK, RD .
VIROLOGY, 1987, 159 (02) :389-398
[7]   HUMAN PAPILLOMAVIRUS AND INVASIVE CERVICAL-CANCER IN BRAZIL [J].
ELUFNETO, J ;
BOOTH, M ;
MUNOZ, N ;
BOSCH, FX ;
MEIJER, CJLM ;
WALBOOMERS, JMM .
BRITISH JOURNAL OF CANCER, 1994, 69 (01) :114-119
[8]  
ERIKSSON A, 1999, J GEN VIROL
[9]  
HAVRE PA, 1995, CANCER RES, V55, P4420
[10]   HPV16 gene variations in invasive cervical squamous cell carcinoma and cancer in situ from Russian patients [J].
Hu, X ;
Pang, T ;
Guo, Z ;
Mazurenko, N ;
Kisseljov, F ;
Pontéen, J ;
Nistéer, M .
BRITISH JOURNAL OF CANCER, 2001, 84 (06) :791-795